FDA may have the answer to its struggles finding and retaining top scientific talent inside its own walls.
Richard Pazdur, director of the Office of New Drugs’ Office of Hematology and Oncology Drug Products, does not seek more industry candidates, as FDA has focused on in
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?